DNA Damage in Chronic Kidney Disease: Evaluation of Clinical Biomarkers

Patients with chronic kidney disease (CKD) exhibit an increased cancer risk compared to a healthy control population. To be able to estimate the cancer risk of the patients and to assess the impact of interventional therapies thereon, it is of particular interest to measure the patients' burden...

Descripción completa

Detalles Bibliográficos
Autores principales: Schupp, Nicole, Stopper, Helga, Heidland, August
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2016
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4897719/
https://www.ncbi.nlm.nih.gov/pubmed/27313827
http://dx.doi.org/10.1155/2016/3592042

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4897719/
https://www.ncbi.nlm.nih.gov/pubmed/27313827
http://dx.doi.org/10.1155/2016/3592042

Ejemplares similares